Anteris Technologies (AU:AVR) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Anteris Technologies successfully closed its U.S. initial public offering, raising approximately $88.8 million with shares now trading on the NASDAQ under the ticker ‘AVR’. The company’s stock will also be listed on the Australian Securities Exchange as CDIs. Proceeds will primarily support the development of their innovative DurAVR® transcatheter heart valve, aimed at treating severe aortic stenosis.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
